The lurbinectedin market is driven by rising cancer prevalence and increasing demand for advanced oncology therapeutics. Ongoing clinical research and expanding treatment approvals are expected to support market growth. https://www.databridgemarketresearch.com/reports/global-lurbinectedin-market